We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Cytomegalovirus (CMV), a common herpes virus, its transmission, symptoms, risks, diagnosis, treatment, and prevention methods, especially for pregnant women and immunocompromised individuals.

Cytomegalovirus (CMV) is a very common virus that belongs to the herpes virus family. While many people might not have heard of it, it's estimated that a significant portion of the population in India, like in the United States, has been exposed to CMV by adulthood. In fact, between 50% and 80% of people in the US are infected by age 40, and about 1 in 3 children in the US contract it by age 5. It's highly likely that similar statistics apply to India, given the global prevalence of this virus.
CMV is a type of herpes virus, meaning it shares characteristics with viruses like the ones that cause chickenpox (varicella-zoster virus) and cold sores (herpes simplex virus). The main similarity among all herpes viruses is their ability to remain dormant in the body for life, potentially reactivating periodically.
While CMV is part of the herpes family, it's important to understand how it differs from other viruses in this group. Unlike herpes simplex virus, CMV does not typically cause cold sores or external ulcers. It also doesn't cause the characteristic blister-like rashes associated with chickenpox. Although CMV can be transmitted through bodily fluids, it is not classified as a sexually transmitted infection (STI) in the same way that certain forms of herpes simplex are.
CMV is a highly contagious virus that spreads through direct contact with infected bodily fluids. These fluids include:
In India, where close contact and shared living spaces are common, transmission can occur easily through everyday interactions, especially among young children in daycare or school settings. It can spread through kissing, sharing utensils, toys, or even close contact with an infected person's urine or saliva. While it can be transmitted through blood transfusions and organ donations, modern screening and treatment methods significantly reduce this risk.
For most healthy individuals, CMV infection often goes unnoticed. Many people are exposed to the virus and develop mild or no symptoms at all. When symptoms do occur, they are often non-specific and can resemble those of a common cold or flu. These may include:
In some cases, CMV can cause a condition similar to mononucleosis (mono), which is also caused by a herpes virus. This can lead to prolonged fatigue and swollen lymph nodes.
While CMV is generally mild for most, it can pose significant risks for certain groups:
About 1% of babies in the United States contract CMV before birth, a condition known as congenital CMV. This is also a concern in India. If a mother contracts CMV for the first time during pregnancy, there's a risk of passing the virus to her baby. Congenital CMV is the most common infectious cause of birth defects and can lead to serious health problems in newborns, including:
It's crucial for pregnant women, especially those with risk factors or symptoms, to discuss CMV with their doctor.
Individuals with weakened immune systems are at a higher risk of developing severe CMV complications. This includes people with HIV/AIDS, those undergoing chemotherapy, organ transplant recipients, and individuals with other conditions that suppress immunity. In these individuals, CMV can reactivate and affect various organs, leading to serious conditions such as:
Diagnosing CMV typically involves laboratory tests that detect the virus or the body's immune response to it. These tests can include:
For pregnant women or newborns, specific testing protocols are followed. A TORCH panel, which includes testing for CMV, is often used during pregnancy to screen for infections that can affect the fetus.
In most healthy individuals, CMV infection does not require specific treatment. The body's immune system usually manages the virus effectively. However, for individuals with weakened immune systems or those with severe CMV disease, antiviral medications may be prescribed. These medications can help control the virus but do not eliminate it from the body. Common antiviral drugs include ganciclovir, valganciclovir, and foscarnet. Treatment is usually managed by a specialist.
Preventing CMV infection involves practicing good hygiene, especially for pregnant women and those who care for young children:
For pregnant women, discussing CMV risks and prevention strategies with their healthcare provider is essential.
You should consult a doctor if:
No, CMV is not considered an STI, although it can be transmitted through sexual contact via bodily fluids like semen. It is primarily spread through close contact with infected saliva, urine, and other bodily fluids.
No, a CMV infection will not result in a positive test for herpes simplex virus. While both are herpes viruses, they are distinct and tested for separately. CMV testing is usually part of a broader panel, like the TORCH panel, used in pregnancy.
Yes, once you are infected with CMV, the virus remains dormant in your body for life. It may reactivate periodically, but often without causing symptoms.
There is no cure for CMV infection. However, for individuals with severe disease or weakened immune systems, antiviral medications can help manage the infection and prevent complications.
The primary risk of CMV for pregnant women is the potential transmission to the fetus, leading to congenital CMV. This can cause serious health problems for the baby, including hearing loss and developmental issues. The risk is highest if the mother contracts CMV for the first time during pregnancy.

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and what results mean for patients.
April 20, 2026

Discover how specialized staining techniques, like Giemsa, are crucial for accurately diagnosing Leishmaniasis, identifying the parasite, and guiding timely treatment. Understand this key diagnostic approach.
April 20, 2026

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and why it's a vital tool in combating this disease.
April 20, 2026